» Articles » PMID: 37964075

Spatial Profiling of Cancer-associated Fibroblasts of Sporadic Early Onset Colon Cancer Microenvironment

Overview
Publisher Springer Nature
Specialty Oncology
Date 2023 Nov 14
PMID 37964075
Authors
Affiliations
Soon will be listed here.
Abstract

The incidence of sporadic early-onset colon cancer (EOCC) has increased worldwide. The molecular mechanisms in the tumor and the tumor microenvironment (TME) in EOCC are not fully understood. The aim of this study is to unravel unique spatial transcriptomic and proteomic profiles in tumor epithelial cells and cancer-associated fibroblasts (CAFs). Here, we divide the sporadic colon cancer tissue samples with transcriptomic data into patients diagnosed with EOCC (<50 yrs) and late-onset colon cancer (LOCC, ≥50 yrs) and then, analyze the data using CIBERSORTx deconvolution software. EOCC tumors are more enriched in CAFs with fibroblast associated protein positive expression (FAP(+)) than LOCC tumors. EOCC patients with higher FAP mRNA levels in CAFs have shorter OS (Log-rank test, p < 0.029). Spatial transcriptomic analysis of 112 areas of interest, using NanoString GeoMx digital spatial profiling, demonstrate that FAP(+) CAFs at the EOCC tumor invasive margin show a significant upregulation of WNT signaling and higher mRNA/protein levels of fibroblast growth factor 20 (FGF20). Tumor epithelial cells at tumor invasive margin of EOCC tumors neighboring FAP(+) CAFs show significantly higher mRNA/protein levels of fibroblast growth factor receptor (FGFR2) and PI3K/Akt signaling activation. NichNET analysis show a potential interaction between FGF20 and FGFFR2. The role of FGF20 in activating FGFR2/pFGFR2 and AKT/pAKT was validated in-vitro. In conclusion, we identify a unique FAP(+) CAF population that showed WNT signaling upregulation and increased FGF20 levels; while neighbor tumor cells show the upregulation/activation of FGFR2-PI3K/Akt signaling at the tumor invasive margin of EOCC tumors.

Citing Articles

Broad-Spectrum Efficacy of CEACAM6-Targeted Antibody-Drug Conjugate with BET Protein Degrader in Colorectal, Lung, and Breast Cancer Mouse Models.

Kogai H, Tsukamoto S, Koga M, Miyano M, Akagi T, Yamaguchi A Mol Cancer Ther. 2025; 24(3):392-405.

PMID: 39812376 PMC: 11876960. DOI: 10.1158/1535-7163.MCT-24-0444.


Induced collagen type-I secretion by hepatocytes of the melanoma liver metastasis is associated with a reduction in tumour-infiltrating lymphocytes.

Mizuno S, Bustos M, Hayashi Y, Abe K, Furuhashi S, Naeini Y Clin Transl Med. 2024; 14(11):e70067.

PMID: 39496484 PMC: 11534464. DOI: 10.1002/ctm2.70067.


Interferon-induced factor 16 is essential in metastatic melanoma to maintain STING levels and the immune responses upon IFN-γ response pathway activation.

Kobayashi Y, Bustos M, Hayashi Y, Yu Q, Hoon D J Immunother Cancer. 2024; 12(10).

PMID: 39424359 PMC: 11492949. DOI: 10.1136/jitc-2024-009590.


The histological and molecular characteristics of early-onset colorectal cancer: a systematic review and meta-analysis.

Lawler T, Parlato L, Andersen S Front Oncol. 2024; 14:1349572.

PMID: 38737895 PMC: 11082351. DOI: 10.3389/fonc.2024.1349572.

References
1.
Foster D, Januszyk M, Delitto D, Yost K, Griffin M, Guo J . Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin. Cancer Cell. 2022; 40(11):1392-1406.e7. PMC: 9669239. DOI: 10.1016/j.ccell.2022.09.015. View

2.
Guinney J, Dienstmann R, Wang X, De Reynies A, Schlicker A, Soneson C . The consensus molecular subtypes of colorectal cancer. Nat Med. 2015; 21(11):1350-6. PMC: 4636487. DOI: 10.1038/nm.3967. View

3.
Hofseth L, Hebert J, Chanda A, Chen H, Love B, Pena M . Early-onset colorectal cancer: initial clues and current views. Nat Rev Gastroenterol Hepatol. 2020; 17(6):352-364. PMC: 10711686. DOI: 10.1038/s41575-019-0253-4. View

4.
Bankhead P, Loughrey M, Fernandez J, Dombrowski Y, McArt D, Dunne P . QuPath: Open source software for digital pathology image analysis. Sci Rep. 2017; 7(1):16878. PMC: 5715110. DOI: 10.1038/s41598-017-17204-5. View

5.
Ballester V, Rashtak S, Boardman L . Clinical and molecular features of young-onset colorectal cancer. World J Gastroenterol. 2016; 22(5):1736-44. PMC: 4724605. DOI: 10.3748/wjg.v22.i5.1736. View